Remus Pharmaceuticals Ltd IPO: Issue Details, Open/Close Date | Research 360 by Motilal Oswal
Back arrow

Remus Pharma.

CMP

7,616.20

+67.00 (0.89%)

  • DRHP
₹1,229

Offer Price

₹ 47.69 Cr

Issue Size

₹ 1,22,900

Min Investment

100

Lot size

Time Line

  • 17
    May 2023
    Open
  • 19
    May 2023
    Close
  • 24
    May 2023
    Finalisation of Basis of Allotment
  • 25
    May 2023
    Initiation of Refunds
  • 26
    May 2023
    Transfer of Shares to Demat Account
  • 29
    May 2023
    Listing Date

Risks

  • There are outstanding legal proceedings involving the Company, its Directors and the company Promoter.

  • The Company is dependent on few numbers of customers for sales. Loss of any of this large customer may affect its revenues and profitability.

  • The Company is dependent on few suppliers for purchase of product. Loss of any of these large suppliers may affect its business operations.

  • The company registered office, corporate office and warehouse, from where we operate are not owned by it.

  • The company relies on third parties for manufacturing products of the Company.

Financials

All values in Cr

Mar-2021 Mar-2022 Mar-2023 3-Yr trend
Revenue 18.42 (54.50%) 24.72 (34.20%) 45.03 (82.20%)
Gross Profit 18.42 (54.50%) 24.72 (34.20%) 45.03 (82.20%)
Net Income 18.42 (54.50%) 24.72 (34.20%) 45.03 (82.20%)
Assets 18.42 (54.50%) 24.72 (34.20%) 45.03 (82.20%)
Liabilities 18.42 (54.50%) 24.72 (34.20%) 45.03 (82.20%)

Book Running Managers

  • Beeline Capital Advisors Pvt Ltd

Registrar & Transfer Agent

Link Intime India Pvt Ltd

C-101 247 Park,
L B S Marg,
Vikhroli West - Mumbai-400083
Phone : 91-22-49186000 Fax: 91-22-49186060

Company Contact Information

1101 to 1103 South Tower One42,
B/H Ashok Vatika Amblibopal Rd,
Ahmedabad - 380054
Phone : 91-079-29999857 Email : cs@remuspharma.com https://www.remuspharma.com

Offer Related Information

Initial public issue of 388000 equity shares of face value of Rs. 10/- each of Remus Pharmaceuticals Limited ("RPL" or the "Company" or the "Issuer") for cash at a price of Rs. 1229/- per equity share including a share premium of Rs. 1219/- per equity share (the "Issue Price") aggregating to Rs. 47.69 crores ("The Issue"), of which 19500 equity shares of face value of Rs. 10/- each for cash at a price of Rs. 1229/- per equity share including a share premium of Rs. 1219/- per equity share... More

Take your research to the next level.
Login now to unlock Exclusive Features!

Download Our App On: